|
|
News Breaks | | | | September 5, 2012 | | 07:51 EDT |  | ACHN, VVUS, BMRN, IDIX, ARIA, GILD, CLVS, ARNA | Citigroup to host a conference
7th Annual Biotech Day Conference is being held in Boston on September 5. | |
|
News For BMRN;ARNA;ARIA;VVUS;CLVS;IDIX;ACHN;GILD From The Last 14 Days Check below for free stories on BMRN;ARNA;ARIA;VVUS;CLVS;IDIX;ACHN;GILD the last two weeks. |
|
|
| May 23, 2013 | | 10:27 EDT | | GILD | Gilead has a conference call hosted by JPMorgan
 Subscribe for More Information | | | May 22, 2013 | | 12:08 EDT |  | ARNA | Options with decreasing implied volatility: ARNA SGMO NTAP CBST GDI
| | | May 21, 2013 | | 16:51 EDT |  | GILD | Gilead's sofosbuvir gets EMA validation, now under assessment
Subscribe for More Information | | | 12:32 EDT | | ARNA | Options with decreasing implied volatility: PXP ARNA BBY OPK CSC
| | | 07:34 EDT | | BMRN, IDIX | UBS to host a conference
Subscribe for More Information | | | May 20, 2013 | | 07:34 EDT | | ARIA, GILD | UBS to host a conference
Subscribe for More Information | | | May 17, 2013 | | 11:53 EDT | | ARNA | Options with decreasing implied volatility: SGMO ARNA CSC ENDP
Subscribe for More Information | | | 08:22 EDT |  | ARIA | ARIAD shares should be bought on weakness, says BMO Capital
Subscribe for More Information | | | May 16, 2013 | | 12:24 EDT |  | BMRN | On The Fly: Midday Wrap
The S&P 500 was virtually unchanged at midday following a deluge of domestic economic data this morning. The S&P began the session in negative territory, but only moderately lower, after investors received a host of data prior to the open, including reports on jobless claims, consumer prices, and housing starts. ECONOMIC EVENTS: In the U.S., initial jobless claims rose 32K to 360K last week, compared to expectations for them to remain relatively stable at 330K. The consumer price index dropped a larger than forecast 0.4% in April, though the "core" CPI rate rose 0.1%, as expected. Housing starts were down 16.5% in April from the prior month, versus an expected decrease of 6.4%, though building permits jumped 14.3% from the prior month, beating an expected increase of 3.8%. The Philadelphia Fed General Business Conditions Index for May came in at -5.2, versus expectations for a +2.2 reading. COMPANY NEWS: Earnings reports from two Dow members, Wal-Mart (WMT) and Cisco (CSCO), sent their shares in opposite directions. Cisco shares advanced 12% to lead the blue chip index after the company's results beat expectations on the top and bottom lines and prompted price target increases at several analyst firms. Wal-Mart, in contrast, lagged all Dow names, sliding 2% after its earnings for the just ended quarter and its view of the current quarter missed the consensus forecast... After the closing bell, Tesla Motors (TSLA) said it intends to raise about $830M by offering 2.7M common shares and $450M in convertible senior notes. CEO Elon Musk will buy $100M worth of the stock and debt, the company said, and its recently high-flying shares rose another 6%. MAJOR MOVERS: Among the notable gainers rising following Cisco's better than expected results and commentary were Ciena (CIEN), which rose 8%, and Cavium (CAVM), which advanced 4%. Also higher were shares of NetApp (NTAP), which gained over 6% after Bloomberg said activist investor Elliott Management has taken a stake in the company and is pushing its board to explore ways to boost shareholder value. Among the noteworthy losers were Oncothyreon (ONTY), which fell 20%, and Biomarin (BMRN), down 5%, after both pharmaceutical companies, among a number of others, published data to be presented at ASCO, an annual meeting of oncologists. Also lower was AMD (AMD), which declined 14% following a downgrade to Sell at Goldman Sachs. INDICES: Near noon, the Dow was up 12.47, or 0.08%, to 15,288.16; the Nasdaq was up 8.74, or 0.25%, to 3,480.36; and the S&P 500 was nearly flat at 1,658.80. | | | 11:50 EDT | | BMRN, GILD | Celgene, Gilead lower after new data published at ASCO
Subscribe for More Information | | | | 10:30 EDT | | ACHN | Achillion management to meet with Maxim
Subscribe for More Information | | | 09:03 EDT | | BMRN | BioMarin volatility low, shares near record high into ACSO
Subscribe for More Information | | | 08:33 EDT | | BMRN | BioMarin abstract showed impressive anti-tumor activity, says Leerink
Subscribe for More Information | | | 07:39 EDT | | CLVS | Clovis Oncology says data to be presented at ASCO annual meeting
Clovis Oncology announced that three abstracts highlighting results from three Phase I studies of the company’s two lead compounds will be presented at the American Society of Clinical Oncology, ASCO, Annual Meeting 2013 in Chicago. Data contained in the published abstracts was current as of the submission deadline of February 5, 2013. Data to be presented in the poster sessions will include data from the trials as of early May, the company said. | | | 07:29 EDT | | ARIA | Leerink to host a bus tour
Boston Biopharma Bus Tour travels throughout Boston on May 16-17. | | | May 15, 2013 | | 18:32 EDT | | GILD | Gilead announces response data from Phase 2 study of Idelalisib
Subscribe for More Information | | | 15:15 EDT | | CLVS | Clovis Oncology lung cancer treatment designated for orphan drug status
Subscribe for More Information | | | 14:03 EDT | | ARNA | Arena Pharma has positive read through from Eisai forecast, says Piper Jaffray
Subscribe for More Information | | | 06:19 EDT | | ARNA | Arena Pharmaceuticals implied volatility at lower end of index mean range
Subscribe for More Information | | | 06:06 EDT | | ACHN | Achillion appoints Dr. David Apelian as Chief Medical Officer
Achillion (ACHN) appointed David Apelian, M.D., Ph.D., MBA, to the position of Executive VP and Chief Medical Officer, effective May 28. Dr. Apelian wll assume responsibility for the clinical development of Achillion's portfolio of compounds to treat HCV. In addition, Achillion also expanded its clinical operations group with the recent addition of Kevin Kucharski, formerly head of clinical operations at Pharmasset (VRUS), who will serve as Senior VP of Clinical Operations. | | |
|
|
|
|
|
|
